diffuse lung diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Idiopathic interstitial pneumonia and other diffuse lung diseases diagnosed based on international guidelines 2) Diffuse pulmonary disease patients whose blood, lung tissue and bronchoalveolar lavage fluid samples had been obtained with consent in previous studies 3) Unrelated patients with diffuse lung disease (parents, children, siblings) 4) Unrelated persons in the Nagahama cohort
Exclusion criteria
Exclusion criteria: 1) Patients who do not give consent to participate in the study or who refuse to participate by opt-out 2) Patients judged to be inappropriate as participants by the judgment of researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence and prognosis of diffuse lung diseases | — |
Secondary
| Measure | Time frame |
|---|---|
| Susceptibility genes of diffuse lung diseases | — |
Countries
Japan
Contacts
Graduate school of medicine, Kyoto university Department of advanced medicine for respiratory failure